©The Author(s) 2015.
World J Cardiol. Nov 26, 2015; 7(11): 707-718
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.707
Published online Nov 26, 2015. doi: 10.4330/wjc.v7.i11.707
Table 2 Alternative strategies of stem cell therapy
| Enhancement of cell survival, mobilization and paracrine secretion |
| Pharmacology (Statins, etc.) |
| Genetic modification (Akt and Ang1, VEGF and SDF-1, HO-1, bFGF/IGF-1/BMP2) |
| Preconditioning (Hypoxia, TLR3 stimulation) |
| Combination of different cell types or delivery approaches |
| MSCs and CSCs |
| Stop-flow (infarct area) and global intracoronary infusion (viable area) |
| Others |
| Cell infusion immediate after revascularization (allogeneic MSCs, CDCs, etc.) |
| Repeated cell infusion |
| Stimulation of exosome release |
| Direct exosome (or microRNAs) injection |
| Cell therapy in hypertrophied myocardium or dysfunction due to congenital heart disease |
- Citation: Suzuki G. Translational research of adult stem cell therapy. World J Cardiol 2015; 7(11): 707-718
- URL: https://www.wjgnet.com/1949-8462/full/v7/i11/707.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i11.707